MedTrace Logo

Vascular Anomaly Pathology and Genomics Biopsy Study

NCT04836884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2022-04-21

No results posted yet for this study

Summary

The purpose of this research is to gather information on the safety and effectiveness of core biopsy of vascular anomalies for clinical pathology and clinical genomics studies.

Conditions

  • Vascular Malformations
  • Vascular Anomaly
  • Hemangioma
  • Arteriovenous Malformations
  • Venous Malformation
  • Klippel Trenaunay Syndrome
  • Lymphatic Malformation

Interventions

PROCEDURE

Percutaneous Vascular Anomaly/Malformation Biopsy

US-guided percutaneous vascular anomaly core needle biopsy of up to 10 cores using an 18-gauge co-axial core needle biopsy device at the time of clinically indicated sclerotherapy, embolization or ablation treatment.

Sponsors & Collaborators

Principal Investigators

  • Emily Bendel, MD · Mayo Clinic

  • David A Woodrum, MD, PhD · Mayo Clinic

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-06
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04836884 on ClinicalTrials.gov